IDH2 and astrocytoma (excluding glioblastoma): Considering the histotype, the integrated diagnosis included astrocytoma, IDH-mutant, WHO grade 2 in 63.2% (12/19) of cases, WHO grade 3 in 21.1% (4/19) of cases, and WHO grade 4 in 15.8% (3/19) of cases.